Application and thinking of minimally invasive transforaminal lumbar interbody fusion in degenerative lumbar diseases.

ABSTRACT:

Background

This study sought to investigate the clinical efficacy and safety of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of lumbar degenerative diseases.

Methods

The clinical data of 55 patients with lumbar degenerative diseases treated at our hospital from January 2018 to January 2020 were analyzed retrospectively. Of the 55 patients, 35 who underwent MIS-TLIF were included in the MIS-TLIF group, and 20 who underwent posterior lumbar interbody fusion (PLIF) were included in the PLIF group. The visual analogue scale (VAS) score, Oswestry disability index (ODI) score, operation time, incision length, intraoperative bleeding, postoperative drainage, postoperative landing time, postoperative hospital stay, postoperative interbody fus

SUBMITTER: Gu S 

PROVIDER: S-EPMC9011304 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature